BLAISE DAVIS: Open Payments
NPI 1114671500 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 35 payments from 11 companies in 2025. Trend: 2023 $686 · 2024 $524 · 2025 $969
Food & beverage: $794Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $231 |
| ABBVIE INC. | 8 | $174 |
| GlaxoSmithKline, LLC. | 7 | $167 |
| Corcept Therapeutics | 3 | $126 |
| Hologic Sales and Service, LLC | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 5 | $84 |
| Novo Nordisk Inc | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
Products named: PROLIA, NUCALA, Korlym, THINPREP 2000 PROCESSOR, LEQVIO, EVENITY, QULIPTA, TEPEZZA.
Industry payments across TX — which companies pay providers there.
